Naser, Iftekhar BinOshin, Sadia Afrin2021-09-292021-09-2920202020-07ID: 15236003http://hdl.handle.net/10361/15075Catalogued from PDF version of thesis.Includes bibliographical references (pages 32-36).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Science in Biotechnology 2020.Psychiatric disorders are complex phenomena that have neurological, genetic and epigenetic bases. The epigenetic underpinnings of such disorders have been discovered and rediscovered in past research and provide a promising ground for drug development involving fewer side effects and faster recovery. This paper illustrates the epigenetics underlying the development of depression, anxiety disorders, and schizophrenia. In addition, it elaborates on epigenetic pharmacotherapy, focusing on HDAC and DNMT inhibitory activities of contemporary medicine and prospective epigenetic drugs.37 Pagesen-USBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Psychiatric epigeneticsPharmacologyDrug developmentHDAC inhibitorDNMT inhibitorThesis